Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 24 to 28, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 24 to 28, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Poll Finds Herd Immunity in U.S. Possible by Summer
FRIDAY, May 28, 2021 (HealthDay News) — Seventy percent of American adults could be vaccinated against COVID-19 by this summer, a new poll suggests.
ED Presentations for Appendicitis, Miscarriage Down in Pandemic
FRIDAY, May 28, 2021 (HealthDay News) — During the COVID-19 pandemic, there was a decrease in presentations to the emergency department for appendicitis and miscarriage, according to a study published online May 25 in CMAJ, the journal of the Canadian Medical Association.
Functional Decline Common in Adults Hospitalized for COVID-19
FRIDAY, May 28, 2021 (HealthDay News) — Forty-five percent of adults hospitalized for COVID-19 experienced functional decline impacting survival, according to a study published online April 30 in PM&R.
Review Shows COVID-19 Symptoms Often Linger
FRIDAY, May 28, 2021 (HealthDay News) — COVID-19 symptoms frequently persist beyond the acute phase of infection, according to a systematic review published online May 26 in JAMA Network Open.
FDA Approves Third COVID-19 Antibody Treatment for Emergency Use
THURSDAY, May 27, 2021 (HealthDay News) — A third antibody treatment designed to keep high-risk COVID-19 patients from being hospitalized was approved for emergency use by the U.S. Food and Drug Administration on Wednesday.
U.S. Intelligence Told to ‘Redouble’ Efforts to Determine Source of COVID-19
THURSDAY, May 27, 2021 (HealthDay News) — The U.S. intelligence community has been told to “redouble” their efforts to learn the origins of the COVID-19 pandemic, President Joe Biden said Wednesday.
Possible Cause Found for Rare Blood Clots Tied to Some COVID-19 Vaccines
THURSDAY, May 27, 2021 (HealthDay News) — The cause of rare blood clots in some people who have received the AstraZeneca and Johnson & Johnson COVID-19 vaccines has been found, researchers report.
COVID-19 Vaccines May Give Protection for Years: Studies
THURSDAY, May 27, 2021 (HealthDay News) — COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime, to people who were previously exposed to the virus, two new studies suggest.
One Dose of BNT162b2 Inadequate for Hemodialysis Patients
THURSDAY, May 27, 2021 (HealthDay News) — For a majority of hemodialysis patients, a single dose of the BNT162b2 severe acute respiratory syndrome coronavirus 2 vaccine fails to elicit a humoral response, according to a study published online May 12 in CMAJ, the journal of the Canadian Medical Association.
CDC Offers Details on SARS-CoV-2 Vaccine Breakthrough Infections
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Trends Reported in Vaccination Coverage for Adolescents for 2025
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
Social Media Warnings Could Discourage Use Among Teens, Young Adults
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths